Landmark trial
A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation Therapy Oncology Group trial 0418
Jhingran A, Winter K, Portelance L, et al. · RTOG
DoseLab summary
RTOG 0418, a phase II study of post-operative pelvic IMRT for endometrial cancer, which tested whether IMRT could be delivered across many centers and tracked bowel toxicity. Citation checked against Europe PMC.
Why this is useful
The multicenter trial that established post-operative pelvic IMRT planning in the US.
Reference details
- Title
- A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation Therapy Oncology Group trial 0418
- Authors / organization
- Jhingran A, Winter K, Portelance L, et al. · RTOG
- Publication / protocol
- Int J Radiat Oncol Biol Phys. 2012;84(1):e23–e28
- Version
- Pending verification
- Year
- 2012
- DOI
- 10.1016/j.ijrobp.2012.02.044
- Disease sites
- GYN
- Topics
- Endometrium, Post-operative, IMRT, RTOG
- Fractionation context
- Pending verification
- Last reviewed by DoseLab
- Pending verification